ContilexTM TS

Canaglif™

ContilexTM TS

Canagliflozin
SGLT2 Inhibitor (Antidiabetic Preparations)

Indication:

Canaglif is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus (T2DM).

Dosage & Administration:

The recommended starting dose of Canaglif is 100 mg once daily and is taken before the first meal of the day. Dose can be increased upto 300 mg once daily in patients tolerating Canaglif 100 mg once daily who have an eGFR of 60 mL/min/1.73 m2 or greater and require additional glycemic control.
If the eGFR of Patients is 45 to 60 mL/min/1.73 m2, the dose of Canaglif should be 100 mg once daily.

Preparation:

Canaglif Tablet: Each box contains 10’s Tablets in blister pack.